prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |33 |34 |35 |36 |37 |38 |39 |40 |41 |42 |review
What do we expect from mammography-based screening for the high risk population?
Ideally it should have 100% sensitivity with no palpable interval cancers popping up between rounds of screening. The detected cancers should all be non-invasive, which means a cure rate approaches 100%. This is probably not realistic, especially for BRCA1 mutation carriers whose tumors tend to invade at a very early stage in their natural history, so we would want the invasive tumors to be no larger than 1 cm and always negative lymph nodes.
Screening mammography doesn’t perform quite that well in the general population and, unfortunately in the high risk population it performs even less well. In 3 studies specifically focused on mutation carriers, mammography missed half the cancers, DCIS was rarely found, and a high percentage of the invasive cancers were large and node positive.